ARRJF
Price
$3.35
Change
+$0.08 (+2.45%)
Updated
Dec 15 closing price
Capitalization
936.37M
Intraday BUY SELL Signals
SHPMF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
8.5B
Intraday BUY SELL Signals
Interact to see
Advertisement

ARRJF vs SHPMF

Header iconARRJF vs SHPMF Comparison
Open Charts ARRJF vs SHPMFBanner chart's image
Arjo AB
Price$3.35
Change+$0.08 (+2.45%)
Volume$1.1K
Capitalization936.37M
Shanghai Pharmaceuticals Holdings
PriceLoading...
Change-$0.00 (-0.00%)
Volume$4.6K
Capitalization8.5B
ARRJF vs SHPMF Comparison Chart in %
ARRJF
Daily Signal:
Gain/Loss:
SHPMF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARRJF vs. SHPMF commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRJF is a Buy and SHPMF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (ARRJF: $3.35 vs. SHPMF: $1.53)
Brand notoriety: ARRJF and SHPMF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: ARRJF: 407% vs. SHPMF: 100%
Market capitalization -- ARRJF: $936.37M vs. SHPMF: $8.5B
ARRJF [@Medical Distributors] is valued at $936.37M. SHPMF’s [@Medical Distributors] market capitalization is $8.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $102B to $0. The average market capitalization across the [@Medical Distributors] industry is $11.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRJF’s FA Score shows that 1 FA rating(s) are green whileSHPMF’s FA Score has 0 green FA rating(s).

  • ARRJF’s FA Score: 1 green, 4 red.
  • SHPMF’s FA Score: 0 green, 5 red.
According to our system of comparison, ARRJF is a better buy in the long-term than SHPMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRJF’s TA Score shows that 0 TA indicator(s) are bullish while SHPMF’s TA Score has 0 bullish TA indicator(s).

  • ARRJF’s TA Score: 0 bullish, 2 bearish.
  • SHPMF’s TA Score: 0 bullish, 1 bearish.
According to our system of comparison, both ARRJF and SHPMF are a bad buy in the short-term.

Price Growth

ARRJF (@Medical Distributors) experienced а 0.00% price change this week, while SHPMF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +4.41%. For the same industry, the average monthly price growth was +1.00%, and the average quarterly price growth was +2.36%.

Industries' Descriptions

@Medical Distributors (+4.41% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMF($8.5B) has a higher market cap than ARRJF($936M). ARRJF has higher P/E ratio than SHPMF: ARRJF (19.08) vs SHPMF (7.12). ARRJF YTD gains are higher at: 9.121 vs. SHPMF (-6.707). SHPMF has higher annual earnings (EBITDA): 11.2B vs. ARRJF (1.97B). SHPMF has more cash in the bank: 44.5B vs. ARRJF (705M). ARRJF has less debt than SHPMF: ARRJF (1.18B) vs SHPMF (53.7B). SHPMF has higher revenues than ARRJF: SHPMF (281B) vs ARRJF (11.2B).
ARRJFSHPMFARRJF / SHPMF
Capitalization936M8.5B11%
EBITDA1.97B11.2B18%
Gain YTD9.121-6.707-136%
P/E Ratio19.087.12268%
Revenue11.2B281B4%
Total Cash705M44.5B2%
Total Debt1.18B53.7B2%
FUNDAMENTALS RATINGS
ARRJF vs SHPMF: Fundamental Ratings
ARRJF
SHPMF
OUTLOOK RATING
1..100
4146
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8377
PRICE GROWTH RATING
1..100
5072
P/E GROWTH RATING
1..100
4487
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRJF's Valuation (16) in the null industry is somewhat better than the same rating for SHPMF (69). This means that ARRJF’s stock grew somewhat faster than SHPMF’s over the last 12 months.

ARRJF's Profit vs Risk Rating (100) in the null industry is in the same range as SHPMF (100). This means that ARRJF’s stock grew similarly to SHPMF’s over the last 12 months.

SHPMF's SMR Rating (77) in the null industry is in the same range as ARRJF (83). This means that SHPMF’s stock grew similarly to ARRJF’s over the last 12 months.

ARRJF's Price Growth Rating (50) in the null industry is in the same range as SHPMF (72). This means that ARRJF’s stock grew similarly to SHPMF’s over the last 12 months.

ARRJF's P/E Growth Rating (44) in the null industry is somewhat better than the same rating for SHPMF (87). This means that ARRJF’s stock grew somewhat faster than SHPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRJFSHPMF
RSI
ODDS (%)
Bearish Trend 2 days ago
29%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
31%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
30%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARRJF
Daily Signal:
Gain/Loss:
SHPMF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LQTI20.160.16
+0.80%
FT Vest Investment Grade & Target Income ETF
AIBU51.000.12
+0.24%
Direxion Daily AI And Big Data Bull 2X
ITDE36.450.06
+0.16%
iShares LifePath Target Date 2045 ETF
EVSB50.830.04
+0.07%
Eaton Vance Ultra-Short Income ETF
CTA27.27-0.10
-0.37%
Simplify Managed Futures Strategy ETF

ARRJF and

Correlation & Price change

A.I.dvisor tells us that ARRJF and SHPMF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARRJF and SHPMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRJF
1D Price
Change %
ARRJF100%
N/A
SHPMF - ARRJF
8%
Poorly correlated
N/A
COSM - ARRJF
5%
Poorly correlated
+1.15%
MAHLY - ARRJF
2%
Poorly correlated
N/A
PDRX - ARRJF
0%
Poorly correlated
N/A
MEPDF - ARRJF
0%
Poorly correlated
N/A
More

SHPMF and

Correlation & Price change

A.I.dvisor tells us that SHPMF and ARRJF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMF and ARRJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMF
1D Price
Change %
SHPMF100%
N/A
ARRJF - SHPMF
8%
Poorly correlated
N/A
SHPMY - SHPMF
7%
Poorly correlated
N/A
ZYXI - SHPMF
5%
Poorly correlated
N/A
COSM - SHPMF
2%
Poorly correlated
+1.15%
MAHLY - SHPMF
2%
Poorly correlated
N/A
More